Free Trial

Oscar Health (NYSE:OSCR) Shares Up 3.2% - Here's What Happened

Oscar Health logo with Finance background

Oscar Health, Inc. (NYSE:OSCR - Get Free Report)'s share price rose 3.2% during mid-day trading on Friday . The company traded as high as $14.17 and last traded at $14.25. Approximately 1,312,899 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 4,358,694 shares. The stock had previously closed at $13.80.

Analyst Upgrades and Downgrades

OSCR has been the topic of a number of recent analyst reports. Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen upgraded shares of Oscar Health from a "hold" rating to a "buy" rating in a research note on Saturday. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Oscar Health currently has an average rating of "Hold" and an average price target of $18.50.

View Our Latest Stock Report on OSCR

Oscar Health Trading Down 0.2%

The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The business's 50-day moving average is $13.73 and its two-hundred day moving average is $14.59. The firm has a market cap of $3.51 billion, a P/E ratio of -688.16 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the prior year, the firm earned $0.62 EPS. The company's revenue for the quarter was up 42.2% compared to the same quarter last year. As a group, analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now owns 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 24.39% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Oscar Health by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after purchasing an additional 700,469 shares during the last quarter. Deerfield Management Company L.P. Series C boosted its holdings in shares of Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after acquiring an additional 3,983,325 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Oscar Health by 4.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock valued at $155,043,000 after acquiring an additional 467,301 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after acquiring an additional 8,051,379 shares in the last quarter. Finally, Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines